Big Pharma to Meet Chinese Pharma in Suzhou

The international biotech and pharma community will converge on Suzhou, China for the ChinaBio ® Partnering Forum 2012 at the Kempinski Hotel Suzhou, May 23–24. Co-organizers ChinaBio ® LLC, a leading life science consulting firm in Shanghai, and EBD Group report that over 700 industry leaders are set to attend the conference including Aosaikang, AstraZeneca, Bayer HealthCare, BeiGene, Boehringer Ingelheim, Eli Lilly, Fosun Pharma, Furen Pharma, Hanmi Pharmaceutical, Hengrui Pharmaceuticals, Hua Medicine, Janssen/J&J, Life Technologies, Lonza, Merck, Novartis, Shire, Simcere and Takeda. Stock Symbols: (NYSE: AZN) (XE: BAY001) (NYSE: LLY) (SHE: 600196) (NYSE: JNJ) (NSDQ: LIFE) (VTX: LONN) (NYSE: MRK) (NYSE: NVS) (LSE:SHP) (NYSE: SCR) (TO: 4502) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});